Contract facts
FederalONCOTYPE DX TESTING - MODIFICATION TO ADD 52.222-90 is a federal award for 257-Network Contract Office 17 (36C257) held by Exact Sciences Corp. Estimated value —. Related solicitation 36C25723Q0917.
ONCOTYPE DX TESTING - MODIFICATION TO ADD 52.222-90
Incumbent footprint
Public recordExact Sciences Corp — $3.8M obligated across 95 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25723A0033?
36C25723A0033 (Oncotype DX testing - modification to) is a 257-Network Contract Office 17 (36C257) award with an estimated value of —, currently held by Exact Sciences Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C257-23-A-0033?
36C257-23-A-0033 is the dashed form of PIID 36C25723A0033 (Oncotype DX testing - modification to), held by Exact Sciences Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25723A0033?
257-Network Contract Office 17 (36C257) awarded 36C25723A0033 to Exact Sciences Corp.
Who is the incumbent on 36C25723A0033?
Exact Sciences Corp is the incumbent with $3.8M across 95 related awards in SCOUT’s public footprint.
When does Exact Sciences Corp’s 36C25723A0033 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.